Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Trials|December 6, 2018
Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
Trials|March 20, 2019
Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trialAngelos G Kolias, Ellie Edlmann, Eric P Thelin, et al.
BMJ Open|March 7, 2023
Targeting patient recovery priorities in degenerative cervical myelopathy: design and rationale for the RECEDE-Myelopathy trial-study protocolBenjamin Davies, Oliver D Mowforth, Stefan Yordanov, et al.
The New England Journal of Medicine|December 16, 2020
Trial of Dexamethasone for Chronic Subdural HematomaPeter J Hutchinson, Ellie Edlmann, Diederik Bulters, et al.
Nature Cardiovascular Research|August 28, 2024
Estrogen receptor alpha deficiency in cardiomyocytes reprograms the heart-derived extracellular vesicle proteome and induces obesity in female miceYow Keat Tham, Bianca C Bernardo, Bethany Claridge, et al.
Scientific Reports|April 12, 2019
Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phaseEllie Edlmann, Eric P Thelin, Karen Caldwell, et al.
Health Technology Assessment (Winchester, England)|March 21, 2024
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)Peter J Hutchinson, Ellie Edlmann, John G Hanrahan, et al.
Trials|January 30, 2024
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stageAlice-Maria Toader, Marion K Campbell, Jennifer K Quint, et al.
Plos Medicine|October 12, 2016
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialJohn A Todd, Marina Evangelou, Antony J Cutler, et al.
The Lancet. Respiratory Medicine|May 16, 2025
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trialsAlain Amstutz, Stefan Schandelmaier, Hannah Ewald, et al.
Pageof 6